Pfizer (PFE)
(Delayed Data from NYSE)
$28.82 USD
+0.44 (1.55%)
Updated May 15, 2024 04:01 PM ET
Pre-Market: $28.92 +0.10 (0.35%) 9:16 AM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Brokerage Reports
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 541 - 557 ( 557 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Despite Headwinds in the U.S. and Europe, Fourth Quarter Revenue Exceeded Expectations
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Management raises guidance for CY10 & maintains earlier guidance for CY12....
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Several Factors Held Back Third Quarter Revenue
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Acquisition of Wyeth to ease pressure on topline.Earnings growth to bounce back to respectable levels in CY10, on back of effective cost cutting measures & Wyeth related merger synergies.
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
With Wyeth in the Fold, Pfizer is Looking Ahead to Merger Synergies and Life After Lipitor
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S